RUBIN PAUL D sold BIOA
February 2, 2026 · Form 4 insider transaction
RUBIN PAUL D sold 7,433 shares of BioAge Labs, Inc. at $18.75 per share, a transaction worth $139.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
7,433
Price
$18.75
Total value
$139.4K
InsiderRUBIN PAUL D
RoleOfficer
CompanyBioAge Labs, Inc. (BIOA)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 2, 2026
Filing dateFebruary 3, 2026
Shares owned after0
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024.